Trial Profile
Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas Combining DC Bead Microspheres Loaded With Idarubicin (Zavedos): Phase I Trial.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Idarubicin (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- Acronyms IDASPHERE
- 21 Jul 2011 Planned End Date changed from 1 Sep 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 21 Jul 2011 Planned End Date changed from 1 Sep 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 08 Jan 2010 New trial record